nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoposide—GSTT1—chronic obstructive pulmonary disease	0.269	0.46	CbGaD
Etoposide—GSTP1—chronic obstructive pulmonary disease	0.213	0.363	CbGaD
Etoposide—CYP1A2—chronic obstructive pulmonary disease	0.104	0.177	CbGaD
Etoposide—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.0453	0.207	CbGbCtD
Etoposide—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0392	0.179	CbGbCtD
Etoposide—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0261	0.119	CbGbCtD
Etoposide—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0227	0.104	CbGbCtD
Etoposide—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0184	0.0843	CbGbCtD
Etoposide—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0125	0.0569	CbGbCtD
Etoposide—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0119	0.0543	CbGbCtD
Etoposide—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0106	0.0484	CbGbCtD
Etoposide—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0104	0.0474	CbGbCtD
Etoposide—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0098	0.0448	CbGbCtD
Etoposide—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00622	0.0284	CbGbCtD
Etoposide—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00587	0.0268	CbGbCtD
Etoposide—GSTT1—respiratory system—chronic obstructive pulmonary disease	0.00198	0.063	CbGeAlD
Etoposide—PTGS2—leg—chronic obstructive pulmonary disease	0.00171	0.0546	CbGeAlD
Etoposide—TOP2B—respiratory system—chronic obstructive pulmonary disease	0.00146	0.0464	CbGeAlD
Etoposide—ABCC6—connective tissue—chronic obstructive pulmonary disease	0.00141	0.045	CbGeAlD
Etoposide—TOP2B—connective tissue—chronic obstructive pulmonary disease	0.00128	0.0409	CbGeAlD
Etoposide—TOP2B—bronchus—chronic obstructive pulmonary disease	0.0012	0.0382	CbGeAlD
Etoposide—TOP2A—Salmeterol—Salbutamol—chronic obstructive pulmonary disease	0.00119	0.807	CbGdCrCtD
Etoposide—TOP2B—smooth muscle tissue—chronic obstructive pulmonary disease	0.00117	0.0374	CbGeAlD
Etoposide—TOP2B—trachea—chronic obstructive pulmonary disease	0.00108	0.0343	CbGeAlD
Etoposide—GSTT1—lung—chronic obstructive pulmonary disease	0.00105	0.0335	CbGeAlD
Etoposide—ABCC3—respiratory system—chronic obstructive pulmonary disease	0.000916	0.0292	CbGeAlD
Etoposide—GSTP1—respiratory system—chronic obstructive pulmonary disease	0.000912	0.0291	CbGeAlD
Etoposide—TOP2A—bronchus—chronic obstructive pulmonary disease	0.000881	0.0281	CbGeAlD
Etoposide—ABCC6—lung—chronic obstructive pulmonary disease	0.000852	0.0272	CbGeAlD
Etoposide—GSTP1—connective tissue—chronic obstructive pulmonary disease	0.000803	0.0256	CbGeAlD
Etoposide—TOP2B—lung—chronic obstructive pulmonary disease	0.000773	0.0247	CbGeAlD
Etoposide—GSTP1—bronchus—chronic obstructive pulmonary disease	0.000751	0.0239	CbGeAlD
Etoposide—ABCC10—bronchus—chronic obstructive pulmonary disease	0.00075	0.0239	CbGeAlD
Etoposide—GSTP1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000735	0.0234	CbGeAlD
Etoposide—GSTP1—trachea—chronic obstructive pulmonary disease	0.000674	0.0215	CbGeAlD
Etoposide—ABCC10—trachea—chronic obstructive pulmonary disease	0.000674	0.0215	CbGeAlD
Etoposide—TOP2A—lung—chronic obstructive pulmonary disease	0.000569	0.0181	CbGeAlD
Etoposide—ABCC1—bronchus—chronic obstructive pulmonary disease	0.000531	0.0169	CbGeAlD
Etoposide—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000514	0.0164	CbGeAlD
Etoposide—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.000496	0.0158	CbGeAlD
Etoposide—ABCC3—lung—chronic obstructive pulmonary disease	0.000487	0.0155	CbGeAlD
Etoposide—GSTP1—lung—chronic obstructive pulmonary disease	0.000484	0.0154	CbGeAlD
Etoposide—ABCC10—lung—chronic obstructive pulmonary disease	0.000484	0.0154	CbGeAlD
Etoposide—ABCC1—trachea—chronic obstructive pulmonary disease	0.000477	0.0152	CbGeAlD
Etoposide—CYP2E1—respiratory system—chronic obstructive pulmonary disease	0.000462	0.0147	CbGeAlD
Etoposide—PTGS1—respiratory system—chronic obstructive pulmonary disease	0.000445	0.0142	CbGeAlD
Etoposide—PTGS2—respiratory system—chronic obstructive pulmonary disease	0.000426	0.0136	CbGeAlD
Etoposide—PTGS1—connective tissue—chronic obstructive pulmonary disease	0.000392	0.0125	CbGeAlD
Etoposide—PTGS2—connective tissue—chronic obstructive pulmonary disease	0.000375	0.0119	CbGeAlD
Etoposide—PTGS1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000359	0.0114	CbGeAlD
Etoposide—PTGS2—bronchus—chronic obstructive pulmonary disease	0.00035	0.0112	CbGeAlD
Etoposide—PTGS2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000343	0.0109	CbGeAlD
Etoposide—ABCC1—lung—chronic obstructive pulmonary disease	0.000342	0.0109	CbGeAlD
Etoposide—PTGS1—trachea—chronic obstructive pulmonary disease	0.000329	0.0105	CbGeAlD
Etoposide—PTGS2—trachea—chronic obstructive pulmonary disease	0.000315	0.01	CbGeAlD
Etoposide—ABCG2—lung—chronic obstructive pulmonary disease	0.000283	0.00904	CbGeAlD
Etoposide—CYP1A2—lung—chronic obstructive pulmonary disease	0.000273	0.0087	CbGeAlD
Etoposide—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000263	0.00839	CbGeAlD
Etoposide—CYP3A5—lung—chronic obstructive pulmonary disease	0.000263	0.00839	CbGeAlD
Etoposide—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000253	0.00256	CcSEcCtD
Etoposide—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000253	0.00256	CcSEcCtD
Etoposide—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000253	0.00255	CcSEcCtD
Etoposide—Chills—Salbutamol—chronic obstructive pulmonary disease	0.000252	0.00254	CcSEcCtD
Etoposide—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.00025	0.00252	CcSEcCtD
Etoposide—Back pain—Formoterol—chronic obstructive pulmonary disease	0.00025	0.00252	CcSEcCtD
Etoposide—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000249	0.00251	CcSEcCtD
Etoposide—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000249	0.00251	CcSEcCtD
Etoposide—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000247	0.00249	CcSEcCtD
Etoposide—Ulcer—Prednisone—chronic obstructive pulmonary disease	0.000246	0.00248	CcSEcCtD
Etoposide—CYP2E1—lung—chronic obstructive pulmonary disease	0.000245	0.00782	CbGeAlD
Etoposide—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000244	0.00246	CcSEcCtD
Etoposide—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000241	0.00243	CcSEcCtD
Etoposide—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.00024	0.00242	CcSEcCtD
Etoposide—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00024	0.00242	CcSEcCtD
Etoposide—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00024	0.00242	CcSEcCtD
Etoposide—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000239	0.00241	CcSEcCtD
Etoposide—PTGS1—lung—chronic obstructive pulmonary disease	0.000236	0.00754	CbGeAlD
Etoposide—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000236	0.00238	CcSEcCtD
Etoposide—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000235	0.00237	CcSEcCtD
Etoposide—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000235	0.00237	CcSEcCtD
Etoposide—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000233	0.00235	CcSEcCtD
Etoposide—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000233	0.00235	CcSEcCtD
Etoposide—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000227	0.00229	CcSEcCtD
Etoposide—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000227	0.00229	CcSEcCtD
Etoposide—PTGS2—lung—chronic obstructive pulmonary disease	0.000226	0.0072	CbGeAlD
Etoposide—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000226	0.00228	CcSEcCtD
Etoposide—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000226	0.00228	CcSEcCtD
Etoposide—Cough—Formoterol—chronic obstructive pulmonary disease	0.000226	0.00228	CcSEcCtD
Etoposide—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000224	0.00226	CcSEcCtD
Etoposide—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000223	0.00225	CcSEcCtD
Etoposide—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000223	0.00225	CcSEcCtD
Etoposide—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.000222	0.00224	CcSEcCtD
Etoposide—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000221	0.00223	CcSEcCtD
Etoposide—Cough—Montelukast—chronic obstructive pulmonary disease	0.000221	0.00223	CcSEcCtD
Etoposide—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00022	0.00222	CcSEcCtD
Etoposide—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00022	0.00222	CcSEcCtD
Etoposide—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00022	0.00222	CcSEcCtD
Etoposide—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00022	0.00222	CcSEcCtD
Etoposide—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000219	0.00221	CcSEcCtD
Etoposide—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000219	0.00221	CcSEcCtD
Etoposide—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000219	0.00221	CcSEcCtD
Etoposide—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000219	0.00221	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000219	0.00221	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000219	0.00221	CcSEcCtD
Etoposide—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.000219	0.00221	CcSEcCtD
Etoposide—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000218	0.00219	CcSEcCtD
Etoposide—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000218	0.00219	CcSEcCtD
Etoposide—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000215	0.00217	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000214	0.00216	CcSEcCtD
Etoposide—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000214	0.00216	CcSEcCtD
Etoposide—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000213	0.00215	CcSEcCtD
Etoposide—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000213	0.00215	CcSEcCtD
Etoposide—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000211	0.00213	CcSEcCtD
Etoposide—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000211	0.00213	CcSEcCtD
Etoposide—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000211	0.00213	CcSEcCtD
Etoposide—Infection—Formoterol—chronic obstructive pulmonary disease	0.00021	0.00212	CcSEcCtD
Etoposide—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00021	0.00212	CcSEcCtD
Etoposide—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000208	0.0021	CcSEcCtD
Etoposide—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000208	0.0021	CcSEcCtD
Etoposide—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000207	0.00209	CcSEcCtD
Etoposide—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000207	0.00209	CcSEcCtD
Etoposide—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000206	0.00208	CcSEcCtD
Etoposide—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000206	0.00208	CcSEcCtD
Etoposide—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.00207	CcSEcCtD
Etoposide—Infection—Montelukast—chronic obstructive pulmonary disease	0.000205	0.00207	CcSEcCtD
Etoposide—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000205	0.00207	CcSEcCtD
Etoposide—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000205	0.00207	CcSEcCtD
Etoposide—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000204	0.00206	CcSEcCtD
Etoposide—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000202	0.00204	CcSEcCtD
Etoposide—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000202	0.00204	CcSEcCtD
Etoposide—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000201	0.00203	CcSEcCtD
Etoposide—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000199	0.00201	CcSEcCtD
Etoposide—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000198	0.002	CcSEcCtD
Etoposide—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000197	0.00199	CcSEcCtD
Etoposide—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000197	0.00199	CcSEcCtD
Etoposide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000196	0.00198	CcSEcCtD
Etoposide—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000196	0.00198	CcSEcCtD
Etoposide—ABCB1—trachea—chronic obstructive pulmonary disease	0.000195	0.0062	CbGeAlD
Etoposide—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.00196	CcSEcCtD
Etoposide—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000194	0.00195	CcSEcCtD
Etoposide—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000193	0.00194	CcSEcCtD
Etoposide—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000193	0.00194	CcSEcCtD
Etoposide—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00019	0.00192	CcSEcCtD
Etoposide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00019	0.00191	CcSEcCtD
Etoposide—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000188	0.0019	CcSEcCtD
Etoposide—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000188	0.0019	CcSEcCtD
Etoposide—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000188	0.00189	CcSEcCtD
Etoposide—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000188	0.00189	CcSEcCtD
Etoposide—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000186	0.00188	CcSEcCtD
Etoposide—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000186	0.00188	CcSEcCtD
Etoposide—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000186	0.00187	CcSEcCtD
Etoposide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000185	0.00187	CcSEcCtD
Etoposide—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000184	0.00185	CcSEcCtD
Etoposide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000183	0.00185	CcSEcCtD
Etoposide—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000182	0.00184	CcSEcCtD
Etoposide—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000182	0.00184	CcSEcCtD
Etoposide—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000182	0.00184	CcSEcCtD
Etoposide—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000182	0.00184	CcSEcCtD
Etoposide—Pain—Formoterol—chronic obstructive pulmonary disease	0.000181	0.00182	CcSEcCtD
Etoposide—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000181	0.00182	CcSEcCtD
Etoposide—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000181	0.00182	CcSEcCtD
Etoposide—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000181	0.00182	CcSEcCtD
Etoposide—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000179	0.00181	CcSEcCtD
Etoposide—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000179	0.0018	CcSEcCtD
Etoposide—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000178	0.0018	CcSEcCtD
Etoposide—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000178	0.00179	CcSEcCtD
Etoposide—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.00179	CcSEcCtD
Etoposide—Pain—Montelukast—chronic obstructive pulmonary disease	0.000177	0.00178	CcSEcCtD
Etoposide—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000177	0.00178	CcSEcCtD
Etoposide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000176	0.00178	CcSEcCtD
Etoposide—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000176	0.00177	CcSEcCtD
Etoposide—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000176	0.00177	CcSEcCtD
Etoposide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000175	0.00176	CcSEcCtD
Etoposide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000175	0.00176	CcSEcCtD
Etoposide—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000174	0.00175	CcSEcCtD
Etoposide—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000174	0.00175	CcSEcCtD
Etoposide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000174	0.00175	CcSEcCtD
Etoposide—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000173	0.00175	CcSEcCtD
Etoposide—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000173	0.00175	CcSEcCtD
Etoposide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000173	0.00174	CcSEcCtD
Etoposide—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000173	0.00174	CcSEcCtD
Etoposide—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000173	0.00174	CcSEcCtD
Etoposide—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000172	0.00174	CcSEcCtD
Etoposide—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000172	0.00173	CcSEcCtD
Etoposide—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00017	0.00172	CcSEcCtD
Etoposide—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00017	0.00172	CcSEcCtD
Etoposide—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000169	0.00171	CcSEcCtD
Etoposide—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000168	0.00169	CcSEcCtD
Etoposide—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000168	0.00169	CcSEcCtD
Etoposide—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000167	0.00168	CcSEcCtD
Etoposide—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000167	0.00168	CcSEcCtD
Etoposide—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000167	0.00168	CcSEcCtD
Etoposide—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000167	0.00168	CcSEcCtD
Etoposide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000166	0.00168	CcSEcCtD
Etoposide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000165	0.00166	CcSEcCtD
Etoposide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000165	0.00166	CcSEcCtD
Etoposide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000165	0.00166	CcSEcCtD
Etoposide—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000164	0.00166	CcSEcCtD
Etoposide—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.00166	CcSEcCtD
Etoposide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000164	0.00165	CcSEcCtD
Etoposide—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000163	0.00165	CcSEcCtD
Etoposide—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000163	0.00165	CcSEcCtD
Etoposide—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.00164	CcSEcCtD
Etoposide—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000161	0.00162	CcSEcCtD
Etoposide—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.0016	CcSEcCtD
Etoposide—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.00159	CcSEcCtD
Etoposide—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.00159	CcSEcCtD
Etoposide—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000156	0.00157	CcSEcCtD
Etoposide—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000156	0.00157	CcSEcCtD
Etoposide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000155	0.00157	CcSEcCtD
Etoposide—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000152	0.00154	CcSEcCtD
Etoposide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000151	0.00153	CcSEcCtD
Etoposide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000151	0.00153	CcSEcCtD
Etoposide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000149	0.00151	CcSEcCtD
Etoposide—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000149	0.00151	CcSEcCtD
Etoposide—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000149	0.0015	CcSEcCtD
Etoposide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000148	0.0015	CcSEcCtD
Etoposide—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.00148	CcSEcCtD
Etoposide—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000146	0.00148	CcSEcCtD
Etoposide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000144	0.00146	CcSEcCtD
Etoposide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000144	0.00146	CcSEcCtD
Etoposide—TOP2A—Methyltestosterone—Prednisone—chronic obstructive pulmonary disease	0.000144	0.0975	CbGdCrCtD
Etoposide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000143	0.00144	CcSEcCtD
Etoposide—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000142	0.00144	CcSEcCtD
Etoposide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000141	0.00143	CcSEcCtD
Etoposide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.00142	CcSEcCtD
Etoposide—TOP2A—Methyltestosterone—Prednisolone—chronic obstructive pulmonary disease	0.000141	0.0952	CbGdCrCtD
Etoposide—ABCB1—lung—chronic obstructive pulmonary disease	0.00014	0.00446	CbGeAlD
Etoposide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00014	0.00141	CcSEcCtD
Etoposide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00014	0.00141	CcSEcCtD
Etoposide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000137	0.00138	CcSEcCtD
Etoposide—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000137	0.00138	CcSEcCtD
Etoposide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000136	0.00138	CcSEcCtD
Etoposide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000134	0.00135	CcSEcCtD
Etoposide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000134	0.00135	CcSEcCtD
Etoposide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000133	0.00134	CcSEcCtD
Etoposide—Rash—Formoterol—chronic obstructive pulmonary disease	0.000133	0.00134	CcSEcCtD
Etoposide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000133	0.00134	CcSEcCtD
Etoposide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000133	0.00134	CcSEcCtD
Etoposide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000132	0.00133	CcSEcCtD
Etoposide—Headache—Formoterol—chronic obstructive pulmonary disease	0.000132	0.00133	CcSEcCtD
Etoposide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.00133	CcSEcCtD
Etoposide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000131	0.00133	CcSEcCtD
Etoposide—Rash—Montelukast—chronic obstructive pulmonary disease	0.00013	0.00132	CcSEcCtD
Etoposide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00013	0.00131	CcSEcCtD
Etoposide—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.00013	0.00131	CcSEcCtD
Etoposide—Headache—Montelukast—chronic obstructive pulmonary disease	0.00013	0.00131	CcSEcCtD
Etoposide—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000128	0.0013	CcSEcCtD
Etoposide—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000128	0.00129	CcSEcCtD
Etoposide—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000128	0.00129	CcSEcCtD
Etoposide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.00128	CcSEcCtD
Etoposide—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.00127	CcSEcCtD
Etoposide—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.00127	CcSEcCtD
Etoposide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000126	0.00127	CcSEcCtD
Etoposide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000126	0.00127	CcSEcCtD
Etoposide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000125	0.00126	CcSEcCtD
Etoposide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000125	0.00126	CcSEcCtD
Etoposide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000125	0.00126	CcSEcCtD
Etoposide—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.00124	CcSEcCtD
Etoposide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000123	0.00124	CcSEcCtD
Etoposide—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000121	0.00122	CcSEcCtD
Etoposide—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000121	0.00122	CcSEcCtD
Etoposide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.00119	CcSEcCtD
Etoposide—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.00119	CcSEcCtD
Etoposide—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.00115	CcSEcCtD
Etoposide—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.00113	CcSEcCtD
Etoposide—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.00111	CcSEcCtD
Etoposide—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000109	0.0011	CcSEcCtD
Etoposide—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000109	0.00109	CcSEcCtD
Etoposide—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000106	0.00107	CcSEcCtD
Etoposide—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000106	0.00107	CcSEcCtD
Etoposide—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000103	0.00104	CcSEcCtD
Etoposide—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.00104	CcSEcCtD
Etoposide—Pain—Prednisolone—chronic obstructive pulmonary disease	9.78e-05	0.000986	CcSEcCtD
Etoposide—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	9.44e-05	0.000953	CcSEcCtD
Etoposide—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	9.42e-05	0.00095	CcSEcCtD
Etoposide—Anaemia—Prednisone—chronic obstructive pulmonary disease	9.41e-05	0.000949	CcSEcCtD
Etoposide—Malaise—Prednisone—chronic obstructive pulmonary disease	9.18e-05	0.000926	CcSEcCtD
Etoposide—Vertigo—Prednisone—chronic obstructive pulmonary disease	9.14e-05	0.000923	CcSEcCtD
Etoposide—Urticaria—Prednisolone—chronic obstructive pulmonary disease	9.08e-05	0.000916	CcSEcCtD
Etoposide—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	8.95e-05	0.000902	CcSEcCtD
Etoposide—Convulsion—Prednisone—chronic obstructive pulmonary disease	8.82e-05	0.00089	CcSEcCtD
Etoposide—Hypertension—Prednisone—chronic obstructive pulmonary disease	8.79e-05	0.000886	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	8.61e-05	0.000868	CcSEcCtD
Etoposide—Discomfort—Prednisone—chronic obstructive pulmonary disease	8.56e-05	0.000864	CcSEcCtD
Etoposide—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	8.42e-05	0.00085	CcSEcCtD
Etoposide—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	8.31e-05	0.000838	CcSEcCtD
Etoposide—Infection—Prednisone—chronic obstructive pulmonary disease	8.25e-05	0.000833	CcSEcCtD
Etoposide—Tachycardia—Prednisone—chronic obstructive pulmonary disease	8.11e-05	0.000818	CcSEcCtD
Etoposide—Skin disorder—Prednisone—chronic obstructive pulmonary disease	8.07e-05	0.000814	CcSEcCtD
Etoposide—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	8.03e-05	0.00081	CcSEcCtD
Etoposide—Anorexia—Prednisone—chronic obstructive pulmonary disease	7.92e-05	0.000799	CcSEcCtD
Etoposide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	7.56e-05	0.000763	CcSEcCtD
Etoposide—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	7.46e-05	0.000752	CcSEcCtD
Etoposide—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	7.22e-05	0.000728	CcSEcCtD
Etoposide—Rash—Prednisolone—chronic obstructive pulmonary disease	7.21e-05	0.000727	CcSEcCtD
Etoposide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	7.2e-05	0.000726	CcSEcCtD
Etoposide—Fatigue—Prednisone—chronic obstructive pulmonary disease	7.16e-05	0.000722	CcSEcCtD
Etoposide—Headache—Prednisolone—chronic obstructive pulmonary disease	7.16e-05	0.000722	CcSEcCtD
Etoposide—Constipation—Prednisone—chronic obstructive pulmonary disease	7.1e-05	0.000717	CcSEcCtD
Etoposide—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	6.85e-05	0.000691	CcSEcCtD
Etoposide—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	6.79e-05	0.000685	CcSEcCtD
Etoposide—Nausea—Prednisolone—chronic obstructive pulmonary disease	6.79e-05	0.000685	CcSEcCtD
Etoposide—Urticaria—Prednisone—chronic obstructive pulmonary disease	6.6e-05	0.000666	CcSEcCtD
Etoposide—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	6.57e-05	0.000662	CcSEcCtD
Etoposide—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	6.57e-05	0.000662	CcSEcCtD
Etoposide—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	6.12e-05	0.000617	CcSEcCtD
Etoposide—Asthenia—Prednisone—chronic obstructive pulmonary disease	5.96e-05	0.000601	CcSEcCtD
Etoposide—Pruritus—Prednisone—chronic obstructive pulmonary disease	5.88e-05	0.000593	CcSEcCtD
Etoposide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	5.68e-05	0.000573	CcSEcCtD
Etoposide—Dizziness—Prednisone—chronic obstructive pulmonary disease	5.49e-05	0.000554	CcSEcCtD
Etoposide—Vomiting—Prednisone—chronic obstructive pulmonary disease	5.28e-05	0.000533	CcSEcCtD
Etoposide—Rash—Prednisone—chronic obstructive pulmonary disease	5.24e-05	0.000528	CcSEcCtD
Etoposide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	5.23e-05	0.000528	CcSEcCtD
Etoposide—Headache—Prednisone—chronic obstructive pulmonary disease	5.2e-05	0.000525	CcSEcCtD
Etoposide—Nausea—Prednisone—chronic obstructive pulmonary disease	4.93e-05	0.000498	CcSEcCtD
Etoposide—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	2.82e-05	0.000447	CbGpPWpGaD
Etoposide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	2.81e-05	0.000446	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—IL6—chronic obstructive pulmonary disease	2.79e-05	0.000442	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	2.78e-05	0.000441	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.76e-05	0.000438	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	2.75e-05	0.000437	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.75e-05	0.000437	CbGpPWpGaD
Etoposide—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	2.75e-05	0.000436	CbGpPWpGaD
Etoposide—PTGS2—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	2.7e-05	0.000429	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	2.7e-05	0.000428	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	2.7e-05	0.000428	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—GC—chronic obstructive pulmonary disease	2.68e-05	0.000425	CbGpPWpGaD
Etoposide—TOP2A—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	2.65e-05	0.00042	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.64e-05	0.000419	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.62e-05	0.000416	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	2.59e-05	0.000412	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	2.58e-05	0.000409	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	2.57e-05	0.000408	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—ALB—chronic obstructive pulmonary disease	2.57e-05	0.000408	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	2.57e-05	0.000408	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	2.57e-05	0.000408	CbGpPWpGaD
Etoposide—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.56e-05	0.000406	CbGpPWpGaD
Etoposide—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.52e-05	0.0004	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.49e-05	0.000395	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.46e-05	0.00039	CbGpPWpGaD
Etoposide—ABCC2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.45e-05	0.000389	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	2.44e-05	0.000387	CbGpPWpGaD
Etoposide—ABCC1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.43e-05	0.000385	CbGpPWpGaD
Etoposide—TOP2A—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	2.42e-05	0.000385	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.39e-05	0.000379	CbGpPWpGaD
Etoposide—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2.37e-05	0.000376	CbGpPWpGaD
Etoposide—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.35e-05	0.000373	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.35e-05	0.000372	CbGpPWpGaD
Etoposide—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.33e-05	0.00037	CbGpPWpGaD
Etoposide—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.32e-05	0.000368	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	2.29e-05	0.000363	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.26e-05	0.000358	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.25e-05	0.000357	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	2.25e-05	0.000356	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	2.24e-05	0.000356	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	2.24e-05	0.000355	CbGpPWpGaD
Etoposide—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.23e-05	0.000354	CbGpPWpGaD
Etoposide—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.2e-05	0.000349	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.19e-05	0.000347	CbGpPWpGaD
Etoposide—PTGS2—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	2.18e-05	0.000346	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	2.14e-05	0.000339	CbGpPWpGaD
Etoposide—ABCG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.13e-05	0.000339	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.12e-05	0.000336	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.1e-05	0.000333	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—GCLC—chronic obstructive pulmonary disease	2.1e-05	0.000333	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	2.09e-05	0.000331	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.08e-05	0.00033	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.07e-05	0.000329	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—GC—chronic obstructive pulmonary disease	2.04e-05	0.000324	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.98e-05	0.000313	CbGpPWpGaD
Etoposide—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.97e-05	0.000313	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.97e-05	0.000313	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.95e-05	0.00031	CbGpPWpGaD
Etoposide—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.95e-05	0.000309	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	1.92e-05	0.000305	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	1.92e-05	0.000304	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—CTGF—chronic obstructive pulmonary disease	1.91e-05	0.000304	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.9e-05	0.000302	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.9e-05	0.000301	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	1.88e-05	0.000299	CbGpPWpGaD
Etoposide—ABCC3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.86e-05	0.000295	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.84e-05	0.000292	CbGpPWpGaD
Etoposide—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.81e-05	0.000288	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	1.79e-05	0.000284	CbGpPWpGaD
Etoposide—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.79e-05	0.000284	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.79e-05	0.000283	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.78e-05	0.000283	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.76e-05	0.00028	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	1.72e-05	0.000274	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.72e-05	0.000273	CbGpPWpGaD
Etoposide—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.72e-05	0.000273	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.71e-05	0.000271	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.7e-05	0.00027	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.7e-05	0.000269	CbGpPWpGaD
Etoposide—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.7e-05	0.000269	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.69e-05	0.000269	CbGpPWpGaD
Etoposide—ABCC1—Disease—HDAC2—chronic obstructive pulmonary disease	1.67e-05	0.000265	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.66e-05	0.000264	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	1.66e-05	0.000264	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.64e-05	0.000261	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.56e-05	0.000247	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.55e-05	0.000247	CbGpPWpGaD
Etoposide—ABCC1—Disease—KL—chronic obstructive pulmonary disease	1.55e-05	0.000246	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.54e-05	0.000245	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.53e-05	0.000243	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.53e-05	0.000242	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.51e-05	0.00024	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.5e-05	0.000238	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.49e-05	0.000236	CbGpPWpGaD
Etoposide—ABCC2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.47e-05	0.000234	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.47e-05	0.000233	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.46e-05	0.000232	CbGpPWpGaD
Etoposide—ABCC1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.46e-05	0.000231	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.45e-05	0.000231	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.45e-05	0.00023	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	1.45e-05	0.00023	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.45e-05	0.000229	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.43e-05	0.000227	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—ALB—chronic obstructive pulmonary disease	1.41e-05	0.000224	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.4e-05	0.000223	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.39e-05	0.00022	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.38e-05	0.00022	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.38e-05	0.000219	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.35e-05	0.000214	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.35e-05	0.000214	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.35e-05	0.000213	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.32e-05	0.000209	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.29e-05	0.000205	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.28e-05	0.000203	CbGpPWpGaD
Etoposide—ABCG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.28e-05	0.000203	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.28e-05	0.000203	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.28e-05	0.000203	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.27e-05	0.000201	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.23e-05	0.000195	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.22e-05	0.000193	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.2e-05	0.000191	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.19e-05	0.00019	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—TP53—chronic obstructive pulmonary disease	1.19e-05	0.00019	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.19e-05	0.000188	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.18e-05	0.000187	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.17e-05	0.000185	CbGpPWpGaD
Etoposide—ABCC1—Disease—ERBB3—chronic obstructive pulmonary disease	1.16e-05	0.000184	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.16e-05	0.000183	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.15e-05	0.000183	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.15e-05	0.000183	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.14e-05	0.00018	CbGpPWpGaD
Etoposide—PTGS2—Disease—HDAC2—chronic obstructive pulmonary disease	1.12e-05	0.000178	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.12e-05	0.000177	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.1e-05	0.000175	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.1e-05	0.000175	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.1e-05	0.000174	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.08e-05	0.000172	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.07e-05	0.00017	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.06e-05	0.000168	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.05e-05	0.000167	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.05e-05	0.000166	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.04e-05	0.000165	CbGpPWpGaD
Etoposide—PTGS2—Disease—KL—chronic obstructive pulmonary disease	1.04e-05	0.000165	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.04e-05	0.000165	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.04e-05	0.000164	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.03e-05	0.000164	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.03e-05	0.000163	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.01e-05	0.000161	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.01e-05	0.00016	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1e-05	0.000159	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1e-05	0.000159	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.74e-06	0.000155	CbGpPWpGaD
Etoposide—ABCC1—Disease—NOS2—chronic obstructive pulmonary disease	9.69e-06	0.000154	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.6e-06	0.000152	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	9.47e-06	0.00015	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	9.45e-06	0.00015	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.31e-06	0.000148	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.27e-06	0.000147	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.17e-06	0.000145	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	9.09e-06	0.000144	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.07e-06	0.000144	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	8.97e-06	0.000142	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.95e-06	0.000142	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	8.92e-06	0.000141	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.83e-06	0.00014	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.73e-06	0.000138	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.71e-06	0.000138	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—ALB—chronic obstructive pulmonary disease	8.71e-06	0.000138	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	8.56e-06	0.000136	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.48e-06	0.000135	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.36e-06	0.000133	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—NOS3—chronic obstructive pulmonary disease	8.33e-06	0.000132	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.29e-06	0.000132	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	8.19e-06	0.00013	CbGpPWpGaD
Etoposide—ABCC1—Disease—SERPINE1—chronic obstructive pulmonary disease	8.16e-06	0.000129	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.91e-06	0.000125	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	7.81e-06	0.000124	CbGpPWpGaD
Etoposide—PTGS2—Disease—ERBB3—chronic obstructive pulmonary disease	7.8e-06	0.000124	CbGpPWpGaD
Etoposide—ABCC1—Disease—NOS3—chronic obstructive pulmonary disease	7.79e-06	0.000124	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.73e-06	0.000123	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.62e-06	0.000121	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.54e-06	0.00012	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.28e-06	0.000115	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.26e-06	0.000115	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.18e-06	0.000114	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.16e-06	0.000114	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	7.13e-06	0.000113	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.1e-06	0.000113	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—ALB—chronic obstructive pulmonary disease	7.07e-06	0.000112	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.93e-06	0.00011	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—ALB—chronic obstructive pulmonary disease	6.82e-06	0.000108	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.77e-06	0.000107	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.73e-06	0.000107	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.69e-06	0.000106	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.67e-06	0.000106	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.57e-06	0.000104	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.52e-06	0.000104	CbGpPWpGaD
Etoposide—PTGS2—Disease—NOS2—chronic obstructive pulmonary disease	6.5e-06	0.000103	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.34e-06	0.000101	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.33e-06	0.0001	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.31e-06	0.0001	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.29e-06	9.98e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	6.24e-06	9.9e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.2e-06	9.84e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—ALB—chronic obstructive pulmonary disease	6e-06	9.52e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.82e-06	9.23e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.78e-06	9.17e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	5.77e-06	9.15e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—NOS3—chronic obstructive pulmonary disease	5.74e-06	9.11e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	5.69e-06	9.03e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.52e-06	8.75e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.48e-06	8.69e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.48e-06	8.69e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—SERPINE1—chronic obstructive pulmonary disease	5.48e-06	8.69e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.4e-06	8.57e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—NOS3—chronic obstructive pulmonary disease	5.23e-06	8.3e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—TGFB1—chronic obstructive pulmonary disease	5.15e-06	8.17e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—EGFR—chronic obstructive pulmonary disease	5.05e-06	8.01e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.04e-06	7.99e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.87e-06	7.73e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	4.81e-06	7.64e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.77e-06	7.57e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—ALB—chronic obstructive pulmonary disease	4.58e-06	7.26e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	4.39e-06	6.97e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—NOS3—chronic obstructive pulmonary disease	4.38e-06	6.95e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.37e-06	6.94e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.31e-06	6.85e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	4.31e-06	6.84e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	4.3e-06	6.82e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.12e-06	6.54e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	4.11e-06	6.53e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.05e-06	6.42e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.02e-06	6.38e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—IL6—chronic obstructive pulmonary disease	3.88e-06	6.16e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.81e-06	6.05e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	3.72e-06	5.91e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	3.56e-06	5.65e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—TGFB1—chronic obstructive pulmonary disease	3.46e-06	5.49e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—EGFR—chronic obstructive pulmonary disease	3.39e-06	5.38e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.38e-06	5.36e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.33e-06	5.28e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	3.25e-06	5.15e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.1e-06	4.92e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.1e-06	4.92e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.94e-06	4.67e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—IL6—chronic obstructive pulmonary disease	2.61e-06	4.13e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	2.59e-06	4.11e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.48e-06	3.93e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2e-06	3.17e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.91e-06	3.03e-05	CbGpPWpGaD
